Byotrol plc (BYOT) Ordinary 0.25p
Byotrol plc is engaged in the development, patenting, licensing and sale of anti- microbial products and technologies for business and consumer use. The Company sells products based on its anti-microbial technology to in the United Kingdom. The Company operates through two segments: Professional (including human health, animal health, facilities management, and food and beverage) and Consumer (including household, skin care and pet care). Its products category includes Coronavirus, Medical Device Cleaning and Disinfection, Defra Tested, Surface Disinfection, Reprocessing of Instruments, Skin Disinfection, Odor Control, Pet Retail, Body Spills and Ancillaries. Its Coronavirus products comprises of CHEMGENE HLD4H UNIVERSAL WIPES, Byotrol Surface Sanitising Wipes, BYOTROL 4IN1 MULTI-PURPOSE SURFACE DISINFECTANT CLEANER, ENVOGENE HLD4E, ANIGENE HLD4V Disinfectant Cleaner. Its Medical Device Cleaning and Disinfection products include REPROZYME Enzymatic Instrument Cleaner and Trionic Wipes.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.